1 Answers

The International Prognostic Scoring System , published in 1997, is used by many doctors to help assess the severity of a patient's myelodysplastic syndrome. Based on the IPSS score, the patient's history, and his/her personal observations, the physician will design a treatment plan to address the MDS.

The IPSS uses three "prognostic indicators" to develop a "score" which may be useful in understanding how the MDS may progress:

Each indicator is rated according to its severity and the ratings are combined into a "score."

Scores are sorted into one of four risk categories:

4 views

Related Questions